Cancer Cell
Volume 24, Issue 4, 14 October 2013, Pages 499-511
Journal home page for Cancer Cell

Article
The Role of Cdk5 in Neuroendocrine Thyroid Cancer

https://doi.org/10.1016/j.ccr.2013.08.027Get rights and content
Under an Elsevier user license
open archive

Highlights

  • Cdk5 and its activators are expressed in human MTC

  • Cdk5 activity drives proliferation of sporadic human MTC cell lines

  • Transgenic expression of the Cdk5 cofactor p25 rapidly induces lethal MTC in mice

  • Rb phosphorylation at Ser807/Ser811 is critical for MTC progression

Summary

Medullary thyroid carcinoma (MTC) is a neuroendocrine cancer that originates from calcitonin-secreting parafollicular cells, or C cells. We found that Cdk5 and its cofactors p35 and p25 are highly expressed in human MTC and that Cdk5 activity promotes MTC proliferation. A conditional MTC mouse model was generated and corroborated the role of aberrant Cdk5 activation in MTC. C cell-specific overexpression of p25 caused rapid C cell hyperplasia leading to lethal MTC, which was arrested by repressing p25 overexpression. A comparative phosphoproteomic screen between proliferating and arrested MTC identified the retinoblastoma protein (Rb) as a crucial Cdk5 downstream target. Prevention of Rb phosphorylation at Ser807/Ser811 attenuated MTC proliferation. These findings implicate Cdk5 signaling via Rb as critical to MTC tumorigenesis and progression.

Cited by (0)